Elevated Tau PET Signal Depends on Abnormal Amyloid Levels and Correlates with Cognitive Impairment in Elderly Persons without Dementia.

Abstract

BACKGROUND:

The recent developed PET ligands for amyloid-β (Aβ) and tau allow these two neuropathological hallmarks of Alzheimer's disease (AD) to be mapped and quantified in vivo and to be examined in relation to cognition.

OBJECTIVE:

To assess the associations among Aβ, tau, and cognition in non-demented subjects.

METHODS:

Three hundred eighty-nine elderly participants without dementia from the Alzheimer's Disease Neuroimaging Initiative underwent tau and amyloid PET scans. Cross-sectional comparisons and longitudinal analyses were used to evaluate the relationship between Aβ and tau accumulation. The correlations between biomarkers of both pathologies and performance in memory and executive function were measured.

RESULTS:

Increased amyloid-PET retention was associated with greater tau-PET retention in widespread cortices. We observed a significant tau increase in the temporal composite regions of interest over 24 months in Aβ+ but not Aβ- subjects. Finally, tau-PET retention but not amyloid-PET retention significantly explained the variance in memory and executive function. Higher level of tau was associated with greater longitudinal memory decline.

CONCLUSION:

These findings suggested PET-detectable Aβ plaque pathology may be a necessary antecedent for tau-PET signal elevation. Greater tau-PET retention may demonstrate poorer cognition and predict prospective memory decline in non-demented subjects.

• Authors: Rui-Qi Zhang, Shi-Dong Chen, Xue-Ning Shen, Yu-Xiang Yang, Jia-Ying Lu, Mei Cui, Chuan-Tao Zuo, Qiang Dong, Lan Tan, Jin-Tai Yu, Alzheimer’s Disease Neuroimaging Initiative
• Journal: Journal of Alzheimer's disease : JAD (J Alzheimers Dis) Vol. 78 Issue 1 Pg. 395-404 ( 2020) ISSN: 1875-8908 [Electronic] Netherlands
• PMID: 32986669 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)

Chemical References

• Amyloid beta-Peptides
• tau Proteins

Topics

• Aged
• Aged, 80 and over
• Amyloid beta-Peptides (metabolism)
• Cognition
• Cognitive Dysfunction (diagnostic imaging, metabolism)
• Cross-Sectional Studies
• Female
• Humans
• Male
• Neuropsychological Tests
• Plaque, Amyloid
• Positron-Emission Tomography (methods)
• tau Proteins (metabolism)